AI-powered simulation software could help biomanufacturers understand the economics and sustainability of protein production at large scale.

The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.

Biofabricate announced the organization will not return to Paris for its next-gen biomaterials summit this year, despite last year's success.

Vijay Pande, PhD, founding investor of Andreessen Horowitz's Bio + Health fund and a general partner with the tech venture capital firm , discusses how AI’s uptake in healthcare will shape its ...

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...